The Medication-Assisted Treatment (MAT) program has been a significant topic of debate in correctional facilities across the United States. MAT involves the use of medications such as Methadone and Buprenorphine to treat individuals with opioid use disorders, aiming to reduce withdrawal symptoms and cravings. While many experts recognize MAT as an important tool in combating addiction, some advocates and prison reform supporters express concerns that these programs may sometimes prioritize maintaining inmates on substances over offering opportunities for full recovery and skill-building. In Ohio, for example, recent expansions to the MAT program have been funded by a $2.8 million, two-year contract with Community Medical Services (CMS) under OhioMHAS, which seeks to provide a continuum of care across the criminal justice system. This expansion means incarcerated individuals can start MAT treatment as soon as they arrive at state prisons, aiming to reduce overdose risks and stabilize health during incarceration. However, critics argue that there is a potential conflict of interest inherent in these programs. The concern is that prisons may financially benefit from sustaining the demand for MAT medications rather than investing sufficiently in rehabilitation programs that develop practical life and vocational skills necessary for successful reintegration after release. This criticism urges a shift in focus from maintaining substance use management alone to fostering comprehensive recovery that encompasses mental health care, education, and workforce readiness. The debate around prisoner treatment is complex, underscoring the need for transparency and a balanced approach. Ideally, MAT should be integrated with counseling, behavioral therapies, and post-release support to help individuals rebuild their lives and reduce recidivism rates. Furthermore, gender-specific considerations—such as the distinct needs of women in prison—must be incorporated into program designs. Advocates stress the importance of examining prison addiction treatment programs critically to ensure they empower inmates towards lasting recovery and independence rather than perpetuating dependency. Supporting inmates with effective recovery strategies and life skills training can ultimately benefit not only the individuals affected but also enhance public safety, reduce incarceration costs, and improve community health outcomes. In conclusion, while MAT programs play a vital role in treating opioid use disorders within prisons, it remains essential to evaluate and reform these initiatives continuously. Stakeholders including policymakers, healthcare providers, and advocacy groups must collaborate to prioritize rehabilitation approaches that restore dignity and offer genuine pathways for inmates to rebuild their lives post-incarceration.